“Global Defibrillators market set to grow to $15bn by 2024” says new Visiongain report
19 December 2018
Visiongain has launched a new pharma report Global Defibrillators Market Report : External Defibrillators, Implantable Cardioverter Defibrillators, Transvenous ICD, Subcutaneous ICD, Single-Chamber ICD, Dual-Chamber ICD, Cardiac Resynchronization Therapy Defibrillators (CRT-D), Manual External Defibrillators, Automated External Defibrillators, Wearable Cardioverter Defibrillators.
Defibrillators are essential in improving the quality of life and overall well-being. The defibrillators industry is highly competitive and diverse with immense potential growth. Drivers for growth include availability of technologically advanced defibrillators, rapidly growing aging population leading to high risk of cardiovascular diseases, growing incidence of cardiovascular diseases and increasing awareness and training programmes related to defibrillators.
The lead analyst of the report commented "Growth in this market is set to be driven by the availability of technologically advanced defibrillators, rapidly growing aging population leading to high risk of cardiovascular diseases, growing incidence of cardiovascular diseases and increasing awareness and training programmes related to defibrillators. However, lack of awareness about sudden cardiac arrest, issues related to the use of defibrillator devices (external and implantable), and unfavourable healthcare reforms in the U.S. are some of the key factors restraining the growth of this market. In addition to this, increasing pricing pressure on market players and frequent product recalls pose major challenges to defibrillator manufacturers."
Leading companies featured in the report include Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Cardiac Science Corporation, LivaNova PLC, Medtronic PLC, Nihon Kohden Corporation, Phillips Healthcare, Physio Control Inc., Zoll Medical Corporation.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.
About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Recent News
Visiongain Publishes Allergy Immunotherapy Market Report 2023-2033
The global Allergy Immunotherapy market is projected to grow at a CAGR of 7.6% by 2033
31 May 2023
Read
Visiongain Publishes AI-based Clinical Trial Solution Providers Market Report 2023-2033
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
26 May 2023
Read
Visiongain Publishes Vaccine Contract Manufacturing Market Report 2023-2033
The global Vaccine Contract Manufacturing Market is projected to grow at a CAGR of 13.2% by 2033
24 May 2023
Read
Visiongain Publishes Cell & Gene Therapy Cold Chain Logistics Market Report 2023-2033
The global Cell & Gene Therapy Cold Chain Logistics market is projected to grow at a CAGR of 15% by 2033